Is new better than tried and tested? Topical atopic dermatitis treatment in context.
作者信息
Abuabara K, Flohr C
机构信息
Program for Clinical Research, Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A.
Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' Hospital NHS Foundation Trust and King's College London, London, U.K.
出版信息
Br J Dermatol. 2018 Mar;178(3):583-584. doi: 10.1111/bjd.16316.
Abstract
摘要
相似文献
1
Is new better than tried and tested? Topical atopic dermatitis treatment in context.新的就比经过检验的更好吗？特应性皮炎局部治疗的背景情况
Br J Dermatol. 2018 Mar;178(3):583-584. doi: 10.1111/bjd.16316.
2
Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review.外用克立硼罗治疗特应性手部皮炎：一项回顾性病历审查
Dermatitis. 2021;32(6):e141-e143. doi: 10.1097/DER.0000000000000793.
3
Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas.皮炎的诊断和管理，包括特应性皮炎、接触性皮炎和手部湿疹。
Med Clin North Am. 2021 Jul;105(4):611-626. doi: 10.1016/j.mcna.2021.04.003.
4
Evaluating crisaborole as a treatment option for atopic dermatitis.评估克立硼罗用于特应性皮炎治疗的选择。
Expert Opin Pharmacother. 2019 Jun;20(9):1057-1063. doi: 10.1080/14656566.2019.1604688. Epub 2019 Apr 19.
5
2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis.2%克立硼罗外用软膏治疗轻至中度特应性皮炎。
Expert Rev Clin Immunol. 2017 May;13(5):415-423. doi: 10.1080/1744666X.2017.1304820. Epub 2017 Apr 5.
6
Crisaborole: A new and effective nonsteroidal topical drug for atopic dermatitis.克立硼罗：一种用于特应性皮炎的新型有效非甾体外用药物。
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12533. Epub 2017 Aug 23.
7
Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment.应对特应性皮炎的免疫发病机制：局部和全身治疗的进展
Semin Cutan Med Surg. 2017 Mar;36(2 Suppl 2):S45-S48. doi: 10.12788/j.sder.2017.012.
8
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.与他克莫司 0.03%相比，他卡西醇可显著改善特应性皮炎患儿的患者和照护者报告结局。
J Eur Acad Dermatol Venereol. 2024 Jul;38(7):1364-1372. doi: 10.1111/jdv.19807. Epub 2024 Feb 15.
9
[Current and upcoming treatments of adult atopic dermatitis].[成人特应性皮炎的当前及未来治疗方法]
Ann Dermatol Venereol. 2017 Dec;144 Suppl 5:VS29-VS37. doi: 10.1016/S0151-9638(18)30089-9.
10
Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis.用于特应性皮炎的2%克立硼罗软膏（优色林）
Skin Therapy Lett. 2019 Mar;24(2):4-6.
引用本文的文献
1
Therapeutic New Era for Atopic Dermatitis: Part 2. Small Molecules.特应性皮炎的治疗新时代：第2部分。小分子
Ann Dermatol. 2021 Apr;33(2):101-107. doi: 10.5021/ad.2021.33.2.101. Epub 2021 Mar 8.
本文引用的文献
1
Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.局部用考尼索罗治疗儿童和成人特应性皮炎的获益程度似乎并不乐观：批判性评价。
Br J Dermatol. 2018 Mar;178(3):659-662. doi: 10.1111/bjd.16046. Epub 2017 Dec 3.
2
Therapeutic pipeline for atopic dermatitis: End of the drought?特应性皮炎的治疗领域：干旱的尽头？
J Allergy Clin Immunol. 2017 Sep;140(3):633-643. doi: 10.1016/j.jaci.2017.07.006.
3
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.2%他克莫司软膏治疗轻中度特应性皮炎患儿和成人的长期安全性。
J Am Acad Dermatol. 2017 Oct;77(4):641-649.e5. doi: 10.1016/j.jaad.2017.06.010. Epub 2017 Aug 18.
4
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.度普利尤单抗联合外用皮质类固醇治疗中重度特应性皮炎的长期管理（LIBERTY AD CHRONOS）：一项为期 1 年、随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4.
5
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.用于治疗儿童和成人特应性皮炎（AD）的新型非甾体磷酸二酯酶 4（PDE4）抑制剂克立硼罗软膏的疗效和安全性。
J Am Acad Dermatol. 2016 Sep;75(3):494-503.e6. doi: 10.1016/j.jaad.2016.05.046. Epub 2016 Jul 11.
6
Atopic dermatitis.特应性皮炎。
Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X. Epub 2015 Sep 13.
7
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.度普利尤单抗治疗中重度特应性皮炎成人患者。
N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768.
8
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.特应性皮炎管理指南：第 3 节。光疗和全身药物治疗与管理。
J Am Acad Dermatol. 2014 Aug;71(2):327-49. doi: 10.1016/j.jaad.2014.03.030. Epub 2014 May 9.
9
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.特应性皮炎管理指南：第 1 节。特应性皮炎的诊断和评估。
J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27.
10
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.1%吡美莫司乳膏（ASM 981）治疗儿童及青少年轻中度特应性皮炎的安全性和有效性。
J Am Acad Dermatol. 2002 Apr;46(4):495-504. doi: 10.1067/mjd.2002.122187.
Zotero 插件